Almirall obtains exclusive global rights to develop and commercialize NN-8828 for use in several fields, including immune inflammatory dermatological diseases
Almirall S.A., a global pharmaceutical...
AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the treatment of adult patients...
Corsearch, leading provider of brand protection and trademark solutions, has announced the launch of its new Industrial Design Search tool, a groundbreaking module within...
Advances include faster and more robust protein structure prediction; higher-quality models of protein/protein interactions; large-scale screening and improved de novo protein design for therapeutics
OpenFold,...
InveniAI® LLC, a global leader in the application of artificial intelligence (AI) and machine learning (ML) tools to revolutionize drug discovery and development, announces a...
LTIMindtree, a global technology consulting and digital solutions company, announced the launch of Navisource.AI, a GenAI powered autonomous sourcing platform. Using the power of...
VIDIZMO, a leading provider of intelligent video content and other digital media management solutions, is excited to announce a strategic technology integration partnership with Axis...